Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000696057 | SCV000824602 | benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002477580 | SCV002782306 | uncertain significance | Epilepsy, familial temporal lobe, 1; Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004740411 | SCV005348011 | uncertain significance | RELN-related disorder | 2024-03-07 | no assertion criteria provided | clinical testing | The RELN c.10357C>T variant is predicted to result in premature protein termination (p.Arg3453*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.024% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |